Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Tefferi A, et al. Among authors: call tg. Blood. 2002 May 15;99(10):3854-6. doi: 10.1182/blood-2001-12-0154. Blood. 2002. PMID: 11986248 Free article. Clinical Trial.
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, James CD, Jelinek DF, Tschumper RC, Hanson CA, Pruthi RK, Witzig TE, Call TG, Kay NE. Dewald GW, et al. Among authors: call tg. Br J Haematol. 2003 Apr;121(2):287-95. doi: 10.1046/j.1365-2141.2003.04265.x. Br J Haematol. 2003. PMID: 12694251 Free article.
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.
Nowakowski GS, Dewald GW, Hoyer JD, Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED, Phyliky RL, Call TG, Shanafelt TD, Kay NE, Zent CS. Nowakowski GS, et al. Among authors: call tg. Br J Haematol. 2005 Jul;130(1):36-42. doi: 10.1111/j.1365-2141.2005.05548.x. Br J Haematol. 2005. PMID: 15982342 Free article.
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
Siddiqui M, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN, Johnston PB, Call TG, Porrata LF. Siddiqui M, et al. Among authors: call tg. Br J Haematol. 2006 Sep;134(6):596-601. doi: 10.1111/j.1365-2141.2006.06232.x. Epub 2006 Aug 1. Br J Haematol. 2006. PMID: 16889618 Free article.
Susceptibility genes and B-chronic lymphocytic leukaemia.
Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR. Slager SL, et al. Among authors: call tg. Br J Haematol. 2007 Dec;139(5):762-71. doi: 10.1111/j.1365-2141.2007.06872.x. Br J Haematol. 2007. PMID: 18021089 Free article. Review.
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE. Shanafelt TD, et al. Among authors: call tg. Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x. Br J Haematol. 2008. PMID: 18275431 Free PMC article.
207 results